Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapyLaura S. Sasportas, Khalid Shah, Randa Kasmieh et al.|Proceedings of the National Academy of Sciences|2009Cited by 454
MicroRNA-21 Knockdown Disrupts Glioma Growth <i>In vivo</i> and Displays Synergistic Cytotoxicity with Neural Precursor Cell–Delivered S-TRAIL in Human GliomasMaarten F. Corsten, Khalid Shah, Ralph Weissleder et al.|Cancer Research|2007Cited by 407
Brain Tumor Cells in Circulation Are Enriched for Mesenchymal Gene ExpressionJames P. Sullivan, Daniel A. Haber, Brian V. Nahed et al.|Cancer Discovery|2014Cited by 251
Immune phenotyping of diverse syngeneic murine brain tumors identifies immunologically distinct typesJasneet Kaur Khalsa, Khalid Shah|Nature Communications|2020Cited by 159
Systemic reprogramming of tumour immunity via IL-10-mRNA nanoparticlesChuang LIU, Wei Tao, Xiangang Huang et al.|Nature Nanotechnology|2025Cited by 21